Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
1,054,443
-
Shares change
-
-228,129
-
Total reported value, excl. options
-
$29,216,470
-
Value change
-
-$6,634,393
-
Number of buys
-
16
-
Number of sells
-
-26
-
Price
-
$27.69
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2022
61 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q2 2022.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,054,443 shares
.
Largest 10 shareholders include UBS Group AG (182,406 shares), BANK OF AMERICA CORP /DE/ (178,467 shares), MORGAN STANLEY (155,312 shares), Raymond James Financial Services Advisors, Inc. (76,355 shares), NTV Asset Management LLC (55,618 shares), ROYAL BANK OF CANADA (43,975 shares), Beacon Pointe Advisors, LLC (37,036 shares), Tower Research Capital LLC (TRC) (35,754 shares), Strategic Financial Services, Inc, (27,950 shares), and ASB Consultores, LLC (25,771 shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.